Call for expansion of antiretroviral coverage by Indian diplomat

6 June 2019
hiv_aids_big

An important player in the global fight against AIDS, India has called for expanding antiretroviral therapy coverage to combat HIV/AIDS. Emphasising the importance of continued political commitment, a senior diplomat has said competing financing demands and changing priorities should not affect efforts to provide adequate resources to fight HIV/AIDS, reports The Pharma Letter’s India correspondent.

Taking a lead in the global fight against AIDS, India is supplying the world with two-thirds of the drugs to treat those infected with HIV, according to Indian diplomat Paulomi Tripathi.

Speaking at the UN General Assembly, Ms Tripathi, a First Secretary in India's UN mission said these affordable generic medicines have helped scale up access to treatment across developing countries, as almost two-thirds of the antiretroviral drugs used globally are supplied by the Indian pharmaceutical industry.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical